HG

Hugh Griffith

CEO

NuCana plc

Edinburgh, Scotland


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
NuCana plc
Industry
biotechnology
Employees
27.0
Seniority
C suite
Annual Revenue
7508000.0

Technologies

Outlook Apache Google Tag Manager Vimeo Bootstrap Framework Mobile Friendly Render

Keywords

biotechnology: pharmaceutical preparations health care protide technology cancer treatment anti-cancer agents nuc-7738 nuc-3373 immunotherapy phosphoramidate chemistry nucleoside analogs chemotherapy improvement cancer drug development phase 2 clinical trials oncology tumor microenvironment dna damage thymidylate synthase inhibition drug safety biopharmaceutical innovation tumor targeting chemotherapy resistance biopharma clinical-stage company treatment outcomes patient survival pharmacokinetic profile nucleotide signaling metabolite generation anti-tumor activity clinical research regulatory affairs orphan drug designation therapeutic strategies disease control rate progression-free survival treatment combinations national cancer organizations fda approvals biomarker development clinical pipelines treatment modalities drug efficacy cancer biomarkers drug commercialization tumor therapy precision medicine drug delivery systems high-dosage administration patient compliance biotech investment advanced solid tumors health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans